Amanote Research
Register
Sign In
Suppressive Activity of a Macrolide Antibiotic, Roxithromycin on Co-Stimulatory Molecule Expression on Mouse Splenocytes in Vivo
Mediators of Inflammation
- Egypt
doi 10.1080/09629350050024375
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Cell Biology
Date
January 1, 2000
Authors
K. Kawazu
M. Kurokawa
K. Asano
A. Mita
M. Adachi
Publisher
Hindawi Limited
Related search
Suppressive Effects of Anti-Allergic Agent Suplatast Tosilate (IPD-1151T) on the Expression of Co-Stimulatory Molecules on Mouse Splenocytesin Vivo
Mediators of Inflammation
Immunology
Cell Biology
Pulmonary Disposition of Roxithromycin (RU 28965), a New Macrolide Antibiotic.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Synergistic Effects of a Macrolide and a Cell Wall-Affecting Antibiotic on Pseudomonas Aeruginosa in Vitro and in Vivo. 1. Combined Effects of a Macrolide and a Peptide Antibiotic.
Journal of Antibiotics
Drug Discovery
Pharmacology
Post-Spaceflight (STS-135) Mouse Splenocytes Demonstrate Altered Activation Properties and Surface Molecule Expression
PLoS ONE
Multidisciplinary
Inhibition of Sulfur Mustard-Induced Cytotoxicity and Inflammation by the Macrolide Antibiotic Roxithromycin in Human Respiratory Epithelial Cells
BMC Cell Biology
Cell Biology
Maridomycin, a New Macrolide Antibiotic. I
Journal of Antibiotics
Drug Discovery
Pharmacology
Phosphatidylinositol-3-Kinase Activity During in Vitro Dendritic Cell Generation Determines Suppressive or Stimulatory Capacity
Immunologic Research
Immunology
Small-Molecule Modulators of the OX40-OX40 Ligand Co-Stimulatory Protein-Protein Interaction
British Journal of Pharmacology
Pharmacology
Chemical Modification of Maridomycin, a New Macrolide Antibiotic
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
